Trial Summary
What is the purpose of this trial?
The proposed study tests the feasibility (Phase I) of PATH neurotraining to improve working memory and attention in mTBI patients rapidly and effectively to provide clinical testing of a therapeutic training for the remediation of cognitive disorders caused by a concussion. This study will contribute to the fundamental knowledge of how to remediate concussions from a mTBI to enhance the health, lengthen the life and reduce the disabilities that result from a mTBI.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a diagnosis of epilepsy, seizure disorder, major depressive disorder, or severe anxiety, you may not be eligible to participate.
What data supports the effectiveness of the treatment N-Back Working Memory Training for concussion?
How is PATH neurotraining treatment different from other concussion treatments?
PATH neurotraining is unique because it uses neurofeedback, a technique that helps patients train their brain responses under minimal stress, which is different from traditional rest or exercise-based concussion treatments. This approach focuses on improving brain function directly, rather than just managing symptoms or physical activity levels.678910
Research Team
Teri Lawton, Ph.D.
Principal Investigator
Perception Dynamics Institute
Eligibility Criteria
This trial is for individuals aged 18-60 who have had a mild traumatic brain injury (mTBI) and score between 19-25 on the MoCA test. Participants must read English, have corrected 20/20 vision, and be able to commit time to complete the study. Those with post-traumatic amnesia over 24 hours, recent mTBI (<3 months), or certain cognitive impairments are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo PATH, N-Back WM, or Sham neurotraining for cognitive improvement
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants may opt into continuation of treatment long-term
Treatment Details
Interventions
- N-Back Working Memory Training (Behavioural Intervention)
- Orientation Discrimination (Behavioural Intervention)
- PATH neurotraining (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Perception Dynamics Institute
Lead Sponsor
University of South Alabama
Collaborator
University of California, San Diego
Collaborator
University of California, Riverside
Collaborator